Related Experiment Video
Updated: Jun 5, 2025
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Prospective Cohort Study Investigating Polyunsaturated Fatty Acids and Chronic Lung Disease in Preterm Infants
Teryn Igawa1, Tessa C Gillespie2, Esther S Kim3
1Department of Pediatrics, Children's Discovery and Innovation Institute, David Geffen School of Medicine UCLA and UCLA Mattel Children's Hospital, Los Angeles.
Insights
Preterm infants with chronic lung disease (CLD) showed lower red blood cell membrane arachidonic acid (ARA) levels. This suggests ARA status may be linked to CLD development in premature infants.
Area of Science:
- Neonatal research
- Nutritional science
- Pulmonology
Background:
- Chronic lung disease (CLD) is a significant complication in premature infants.
- Existing research on long-chain polyunsaturated fatty acids (LC-PUFAs) and CLD presents conflicting findings.
- Investigating LC-PUFAs within the red blood cell membrane (RBCM) offers insights into their role in CLD.
Purpose of the Study:
- To examine the association between red blood cell membrane (RBCM) long-chain polyunsaturated fatty acids (LC-PUFAs) and chronic lung disease (CLD) in preterm infants.
- To compare LC-PUFA levels in preterm infants with and without CLD.
- To analyze LC-PUFA status in relation to CLD severity.
Main Methods:
- Prospective observational study of preterm infants (gestational age <32 weeks or birth weight <2 kg).
- LC-PUFA levels in the red blood cell membrane (RBCM) were measured within the first month of life.
- Infants were categorized into control (CON) and chronic lung disease (CLD) groups, with further stratification by CLD severity.
Main Results:
- Infants with CLD exhibited similar RBCM linoleic acid (LA) but lower arachidonic acid (ARA) compared to controls.
- Higher RBCM α-linolenic acid (ALA) was observed in the CLD group, while docosahexaenoic acid (DHA) levels were similar.
- These trends in LC-PUFA levels persisted when analyzed by CLD severity.
Conclusions:
- Lower arachidonic acid (ARA) status is associated with chronic lung disease (CLD) in preterm infants.
- The findings suggest a potential role for ARA in the pathogenesis or prevention of CLD.
- Further research is warranted to explore the therapeutic potential of LC-PUFAs in managing CLD.
Abstract:
Chronic lung disease (CLD) is a complication of prematurity. Studies examining the effects of long-chain polyunsaturated fatty acids (LC-PUFAs) on CLD are conflicting. This study investigated LC-PUFAs in the red blood cell membrane (RBCM) in preterm infants.This prospective observational study included infants with gestational age <32 weeks or birth weight <2 kg and at least one LC-PUFA measurement in the first month of life. Subjects without CLD (CON group) were compared with those with CLD (CLD group) and then by CLD severity.Seventy infants were included (CON n = 29; CLD n = 41). Twenty-six infants had Grade 1 CLD; 12 had Grade 2 CLD; 3 had Grade 3 CLD. When the CLD group was compared with the CON group, the overall mean (95% confidence interval) RBCM% for linoleic acid (LA) was similar (CLD vs. CON 12.5% [11.7-13.4%] vs. 11.2% [10.2-12.3%], p = 0.06) but the overall mean arachidonic acid (ARA) was lower (17.6% [17.1-18.0%] vs. 18.6% [18.1-19.2%], p < 0.01). During weeks 1 to 4, LA% was similar, while ARA% was lower in weeks 2 and 3 (18.8 ± 2.2% vs. 20.0 ± 1.5%, p = 0.05, 16.8 ± 2.0% vs. 18.3 ± 1.6%, p = 0.01). A similar trend was noted when groups were compared by CLD severity. The CLD group had a higher overall mean α-linolenic acid (ALA) compared with the CON group (0.4% [0.3-0.4%] vs. 0.2% [0.2-0.3%], p < 0.01) but no difference in docosahexaenoic acid (DHA; 3.8% [3.4-4.1%] vs. 3.8% [3.4-4.3%], p = 0.80). During weeks 1 to 4, ALA% was higher during week 1 only (0.4 ± 0.3% vs. 0.2 ± 0.1%, p < 0.01), and DHA% was similar for weeks 1 to 4. Results were similar when groups were compared by CLD severity.In this study, low ARA status was associated with CLD. · In this study, infants with CLD had a similar RBCM% of LA, but a lower percentage of its downstream LC-PUFA, ARA, compared with infants without CLD.. · In this study, infants with CLD had a higher RBCM% of α-linolenic acid, but a similar percentage of its downstream LC-PUFA, DHA, compared with infants without CLD.. · In this study, these trends were similiar when groups were compared by CLD severity..
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:11Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...